[REGN] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
06-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 7.84%
YoY- 53.14%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 1,933,700 1,711,800 1,927,800 1,663,496 1,608,022 1,511,485 1,582,447 14.34%
PBT 224,700 546,100 676,200 635,861 656,074 585,398 554,767 -45.34%
Tax 31,600 85,000 -144,200 41,206 104,662 107,418 381,248 -81.07%
NP 193,100 461,100 820,400 594,655 551,412 477,980 173,519 7.40%
Tax Rate -14.06% -15.56% 21.33% -6.48% -15.95% -18.35% -68.72% -
Total Cost 1,740,600 1,250,700 1,107,400 1,068,841 1,056,610 1,033,505 1,408,928 15.17%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 9.99 26.94 42.56 35.75 34.29 31.62 10.97 -6.06%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS 1.77 4.23 7.58 5.51 5.12 4.44 1.62 6.09%
EPS Diluted 1.68 3.99 7.15 5.17 4.82 4.16 1.49 8.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.